Literature DB >> 23549220

Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis.

Susan J Robertson1, Jun Yu Zhou, Kaoru Geddes, Stephen J Rubino, Joon Ho Cho, Stephen E Girardin, Dana J Philpott.   

Abstract

Patients with inflammatory bowel diseases (IBD) harbour intestinal bacterial communities with altered composition compared with healthy counterparts; however, it is unknown whether changes in the microbiota are associated with genetic susceptibility of individuals for developing disease or instead reflect other changes in the intestinal environment related to the disease itself. Since deficiencies in the innate immune receptors Nod1 and Nod2 are linked to IBD, we tested the hypothesis that Nod-signaling alters intestinal immune profiles and subsequently alters bacterial community structure. We used qPCR to analyze expression patterns of selected immune mediators in the ileum and cecum of Nod-deficient mice compared with their Nod-sufficient littermates and assessed the relative abundance of major bacterial groups sampled from the ileum, cecum and colon. The Nod1-deficient ileum exhibited significantly lower expression of Nod2, Muc2, α- and β-defensins and keratinocyte-derived chemokine (KC), suggesting a weakened epithelial barrier compared with WT littermates; however, there were no significant differences in the relative abundance of targeted bacterial groups, indicating that Nod1-associated immune differences alone do not promote dysbiosis. Furthermore, Nod2-deficient mice did not display any changes in the expression of immune markers or bacterial communities. Shifts in bacterial communities that were observed in this study correlated with housing conditions and were independent of genotype. These findings emphasize the importance of using F2 littermate controls to minimize environmental sources of variation in microbial analyses, to establish baseline conditions for host-microbe homeostasis in Nod-deficient mice and to strengthen models for testing factors contributing to microbial dysbiosis associated with IBD.

Entities:  

Keywords:  Nod-like receptors; gut bacterial communities; homeostasis; inflammation; intestinal environment

Mesh:

Substances:

Year:  2013        PMID: 23549220      PMCID: PMC3669167          DOI: 10.4161/gmic.24373

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  45 in total

1.  Genotype is a stronger determinant than sex of the mouse gut microbiota.

Authors:  Amir Kovacs; Noa Ben-Jacob; Hanna Tayem; Eran Halperin; Fuad A Iraqi; Uri Gophna
Journal:  Microb Ecol       Date:  2010-12-23       Impact factor: 4.552

2.  Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract.

Authors:  Koichi S Kobayashi; Mathias Chamaillard; Yasunori Ogura; Octavian Henegariu; Naohiro Inohara; Gabriel Nuñez; Richard A Flavell
Journal:  Science       Date:  2005-02-04       Impact factor: 47.728

3.  Murine beta-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity.

Authors:  Randall S Burd; Jason L Furrer; Janet Sullivan; Arnold L Smith
Journal:  Shock       Date:  2002-11       Impact factor: 3.454

4.  Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.

Authors:  Daniel N Frank; Charles E Robertson; Christina M Hamm; Zegbeh Kpadeh; Tianyi Zhang; Hongyan Chen; Wei Zhu; R Balfour Sartor; Edgar C Boedeker; Noam Harpaz; Norman R Pace; Ellen Li
Journal:  Inflamm Bowel Dis       Date:  2010-09-13       Impact factor: 5.325

5.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.

Authors:  J P Hugot; M Chamaillard; H Zouali; S Lesage; J P Cézard; J Belaiche; S Almer; C Tysk; C A O'Morain; M Gassull; V Binder; Y Finkel; A Cortot; R Modigliani; P Laurent-Puig; C Gower-Rousseau; J Macry; J F Colombel; M Sahbatou; G Thomas
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis.

Authors:  M Wlodarska; B Willing; K M Keeney; A Menendez; K S Bergstrom; N Gill; S L Russell; B A Vallance; B B Finlay
Journal:  Infect Immun       Date:  2011-02-14       Impact factor: 3.441

7.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

8.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

9.  An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid.

Authors:  Mathias Chamaillard; Masahito Hashimoto; Yasuo Horie; Junya Masumoto; Su Qiu; Lisa Saab; Yasunori Ogura; Akiko Kawasaki; Koichi Fukase; Shoichi Kusumoto; Miguel A Valvano; Simon J Foster; Tak W Mak; Gabriel Nuñez; Naohiro Inohara
Journal:  Nat Immunol       Date:  2003-06-06       Impact factor: 25.606

10.  Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan.

Authors:  Stephen E Girardin; Ivo G Boneca; Leticia A M Carneiro; Aude Antignac; Muguette Jéhanno; Jérôme Viala; Karsten Tedin; Muhamed-Kheir Taha; Agnes Labigne; Ulrich Zähringer; Anthony J Coyle; Peter S DiStefano; John Bertin; Philippe J Sansonetti; Dana J Philpott
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

View more
  61 in total

Review 1.  Dysbiosis and the immune system.

Authors:  Maayan Levy; Aleksandra A Kolodziejczyk; Christoph A Thaiss; Eran Elinav
Journal:  Nat Rev Immunol       Date:  2017-03-06       Impact factor: 53.106

Review 2.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 3.  The genetic predisposition and the interplay of host genetics and gut microbiome in Crohn disease.

Authors:  Hu Jianzhong
Journal:  Clin Lab Med       Date:  2014-09-15       Impact factor: 1.935

Review 4.  Role of Autophagy in the Maintenance of Intestinal Homeostasis.

Authors:  Leigh A Baxt; Ramnik J Xavier
Journal:  Gastroenterology       Date:  2015-07-11       Impact factor: 22.682

Review 5.  From sensing to shaping microbiota: insights into the role of NOD2 in intestinal homeostasis and progression of Crohn's disease.

Authors:  Iyshwarya Balasubramanian; Nan Gao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-04-27       Impact factor: 4.052

6.  Peptidoglycan recognition protein 3 and Nod2 synergistically protect mice from dextran sodium sulfate-induced colitis.

Authors:  Xuefang Jing; Fareeha Zulfiqar; Shin Yong Park; Gabriel Núñez; Roman Dziarski; Dipika Gupta
Journal:  J Immunol       Date:  2014-08-11       Impact factor: 5.422

7.  Critical design aspects involved in the study of Paneth cells and the intestinal microbiota.

Authors:  Michael T Shanahan; Ian M Carroll; Ajay S Gulati
Journal:  Gut Microbes       Date:  2013-12-20

Review 8.  Immune and genetic gardening of the intestinal microbiome.

Authors:  Jonathan P Jacobs; Jonathan Braun
Journal:  FEBS Lett       Date:  2014-03-05       Impact factor: 4.124

Review 9.  Peptidoglycan recognition by the innate immune system.

Authors:  Andrea J Wolf; David M Underhill
Journal:  Nat Rev Immunol       Date:  2018-01-02       Impact factor: 53.106

Review 10.  Immune-microbiota interactions in health and disease.

Authors:  Noah W Palm; Marcel R de Zoete; Richard A Flavell
Journal:  Clin Immunol       Date:  2015-06-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.